The fungal meningitis outbreak can serve as a reminder of the need for risk management.
Democrats, Republicans Come Together to Condemn PBMs
In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
Q&A: What the NCPA is Doing to Fight Back Against PBMs
Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
FTC Issues First Report Regarding Ongoing PBM Inquiry
The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.
Walgreens to Close Significant Number of Stores in Continued Erosion of Pharmacy Landscape
“Retail pharmacy is central to our future and to our overall customer and patient experience. It enables many other things, but it has to change,” said Walgreens CEO Tim Wentworth.